Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MRTX1719
i
Other names:
MRTX1719
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Mirati
Drug class:
PRMT5 inhibitor
Related drugs:
‹
TNG908 (3)
EPZ015666 (2)
PRT543 (2)
MRTX9768 (1)
PRT811 (1)
TNG462 (1)
GSK3326595 (1)
TNG908 (3)
EPZ015666 (2)
PRT543 (2)
MRTX9768 (1)
PRT811 (1)
TNG462 (1)
GSK3326595 (1)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
MTAP deletion
Solid Tumor
MTAP deletion
Solid Tumor
MRTX1719
Sensitive: D – Preclinical
AACR 2023 - 1 week (New D)
MRTX1719
Sensitive
:
D
AACR 2023 - 1wk
MRTX1719
Sensitive: D – Preclinical
AACR 2023 - 1 week
MRTX1719
Sensitive
:
D
AACR 2023 - 1 week - (New D)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login